We are live on
!
Find out more
PVLA
Palvella Therapeutics
PVLA
PVLA
180 hedge funds and large institutions have $1.65B invested in Palvella Therapeutics in 2026 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
276% more call options, than puts
Call options by funds: $53.5M | Put options by funds: $14.2M
210% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 21
117% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 30
61% more capital invested
Capital invested by funds: $1.02B → $1.65B (+$626M)
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
29.57% more ownership
Funds ownership: 82.45% → 112.03% (+30%)
29% more funds holding
Funds holding: 140 → 180 (+40)
Holders
180
Holders Change
+40
Holders Change %
+28.57%
% of All Funds
2.22%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
65
Increased
65
Reduced
30
Closed
21
Calls
$53.5M
Puts
$14.2M
Net Calls
+$39.3M
Net Calls Change
+$29.3M
Top Buyers
Top Sellers
| 1 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$40.8M |
| 2 |
PA
Perceptive Advisors
New York
|
-$27.9M |
| 3 |
FAM
Fred Alger Management
New York
|
-$13.4M |
| 4 |
Morgan Stanley
New York
|
-$9.67M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.92M |
